ER
EROC
ERock, Inc.
$16.95
-5.41%
$3.7B
No data for this timeframe.
Vol
Market Cap$3.7B
Cap SizeMid Cap
SEC Reports10
Recent Activity
Jun 11, 2026
Insider
BOYNTON CHARLES D was granted 13,024 shares
Director
Jun 11, 2026
Insider
Brouillette Dan was granted 13,024 shares
Director
Jun 11, 2026
Insider
Patterson Mark R was granted 13,024 shares
Director
Jun 10, 2026
SEC
ERock, Inc. has priced its IPO of 27,906,977 shares of Class A common stock at $21.50 per share, generating $600.0 milli
424B4 — Impact 7/10
Jun 10, 2026
SEC
ERock, Inc.'s S-1 registration statement (File No. 333-295965) was declared effective by the SEC on June 9, 2026, cleari
EFFECT — Impact 5/10
Jun 10, 2026
SEC
Livingston L. Satterthwaite filed an initial Statement of Beneficial Ownership (Form 3) with the SEC, indicating a new i
3 — Impact 2/10
Latest Reports
BULLISH
424B4
7/10
ERock, Inc. has priced its IPO of 27,906,977 shares of Class A common stock at $21.50 per share, generating $600.0 milli
Jun 10, 2026
NEUTRAL
EFFECT
5/10
ERock, Inc.'s S-1 registration statement (File No. 333-295965) was declared effective by the SEC on June 9, 2026, cleari
Jun 10, 2026
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 11, 2026 | BOYNTON CHARLES | A | $0.00 |
| Jun 11, 2026 | Brouillette Dan | A | $0.00 |
| Jun 11, 2026 | Patterson Mark | A | $0.00 |
| Jun 11, 2026 | SATTERTHWAITE LIVINGSTON | A | $0.00 |
| Jun 11, 2026 | Amthor Corey | D | $0.00 |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
6 unique insiders with 8 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | BOYNTON CHARLES D | Director | AWARD | 13,024 | — | — |
| Jun 11, 2026 | Brouillette Dan | Director | AWARD | 13,024 | — | — |
| Jun 11, 2026 | Patterson Mark R | Director | AWARD | 13,024 | — | — |
| Jun 11, 2026 | SATTERTHWAITE LIVINGSTON | Director | AWARD | 13,024 | — | — |
| Jun 11, 2026 | Amthor Corey | President | D | 617,442 | — | — |
| Jun 11, 2026 | Amthor Corey | President | D | 617,442 | $19.85 | $12.3M |
| Jun 11, 2026 | Blakely Robert Ian | Chief Financial Officer | D | 449,233 | — | — |
| Jun 11, 2026 | Blakely Robert Ian | Chief Financial Officer | D | 449,233 | $19.85 | $8.9M |
10 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 9 neutral. Avg impact: 3.3/10.
BULLISH
424B4
7/10
ERock, Inc. has priced its IPO of 27,906,977 shares of Class A common stock at $21.50 per share, gen
Jun 10, 2026
NEUTRAL
EFFECT
5/10
ERock, Inc.'s S-1 registration statement (File No. 333-295965) was declared effective by the SEC on
Jun 10, 2026
NEUTRAL
3
2/10
Livingston L. Satterthwaite filed an initial Statement of Beneficial Ownership (Form 3) with the SEC
Jun 10, 2026
NEUTRAL
3
2/10
Mark R. Patterson filed a Form 3 initial statement of beneficial ownership with the SEC, reporting 5
Jun 10, 2026
NEUTRAL
3
1/10
Charles D. Boynton filed a Form 3 initial statement of beneficial ownership with the SEC, indicating
Jun 10, 2026
NEUTRAL
3
2/10
Hans Kobler filed a Form 3 initial statement of beneficial ownership upon becoming a nominee to the
Jun 10, 2026
NEUTRAL
3
2/10
John E. Carrington filed a Form 3 initial statement of beneficial ownership with the SEC, disclosing
Jun 10, 2026
NEUTRAL
S-1/A
4/10
ERock, Inc. filed Amendment No. 3 to its S-1 registration statement, confirming the IPO of 27,906,97
Jun 5, 2026
NEUTRAL
S-1/A
4/10
ERock, Inc. filed Amendment No. 2 to its S-1 registration statement for an IPO of 27,906,977 shares
Jun 1, 2026
NEUTRAL
S-1/A
4/10
ERock, Inc. filed an amended S-1 registration statement for its initial public offering of Class A c
May 26, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.